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Summary: Two immuno-assay methods (RIA and ELISA) have been developed for the accurate and sensitive
measurement of cotinine in human body fluids (serum, saliva).
RIA uses [3H]cotinine s antigen and charcoal/dextran for separating cotinine-bound antibodies from the free
derivative.
Another technique (ELISA) was developed to avoid the use of radio-labelled compounds and to determine
cotinine in large populations, including passive or non-smokers who usually present very low concentrations.
The two techniques were analytically validated. The detection limit was similar (0.1 μg/l) and the precision
was better than 10% for both techniques.
Non-smoker values ranged from 0.1 to 17 μg/l by ELISA and 0.1 to 27.5 μg/l by RIA, whereas smoker values
ranged from 50 to 1000 μ§/1 (ELISA) and from 70 to 800 μ^ (RIA).
The comparative nalysis of cotinine in 96 human sera revealed a good c rrelation between the two methods
(r = 0.97) and a reliable discrimination between the populations of non-smokers and smokers. As usual, the
ELISA is more rapid (4h 30min) than the RIA (longer than 48h). ELISA is proposed for use in the
epidemiological investigation of the human tobacco risk.
on
 Cotinine elimination in different body fluids varies
Cotinine is the major metabolite of nicotine. In hu- significantly (2). In adult non-smokers, the serum
mans, 70% of nicotine is met bolized (oxidized) to concentration of cotinine is 1.5 μg/lJ and concentra-
cotinine, 4% is oxidized differently, 9% is excreted tions in saliva and urine are 1.7 and 5.0 μ§/1, respec-
unchanged in urine and the metabolic fate of the tively. In smokers, these values increase about 180
remaining 17% is still unknown (1). fold in plasma and in saliva, and 280 fold in urine
(3). Serum cotinine is considered to be a useful bio-
:
 logical indicator of environmental-tobacco-smoke ex-
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tinine level is 0.20 ± 0.44 μ^Ι and 1.87 ± 2.38
respectively. This difference was greater when children
were exposed to tobacco (4).
The technique of Langone et al. (6), s modified by
Castro et al. (5) uses tritium-labelled cotinine, and
charcoal adsorption for separating the cotinine-bound
antibodies from the free derivative. No improvement
of the detection limit of this test in serum has been
reported. Recently, Greenberg et al. (7) achieved a
detection limit of 0.37 μg/l using 125I-labelled cotinine.
The aim of this work was to develop a sensitive radio-
immuno-assay (RIA) and a one-site enzymometric
assay (ELISA) for the quantification of cotinine. The
most convenient of these methods for routine work
will be used for epidemiological studies, which require
reliable discrimination between active smokers, pas-
sive smokers and non-smokers.
Materials and Methods
Reagents
All reagents were of analytical grade. 7ra/7,s-4'-carboxycotinine
and sheep cotinine antiserum prepared using /ra/7i-4'-carboxy-
cotinine conjugated to keyhole limpet haemocyanin s immu-
nogen (cross-reaction at 50% displacement was 100% for co-
tinine and less than 1% for nicotine) were obtained from
International Laboratory Services (London, OB). 3H-labelled
cotinine (specific activity 57.8 TBq/mol) was obtained from
Amersham (Aylesburg, GB). Charcoal-dextran was from
C.E.A. (Gif/Yvette, F), Gelatin-Bacto from Difco (Detroit,
Mi, USA), Casein vitamin-free from Serva (Heidelberg, D), and
Protein A sepharose from Pharmacia (Uppsala, S). Biotin ami-
docaproate-N-hydroxysuccinimide ester, extravidin peroxidase
conjugate, o-phenylenediamine dihydrochloride, hydrogen per-
oxide 30% (300 g/kg), polylysine, (-)cotinine, and l-ethyl-3-
(3-dimethylaminopropyl) carbodiimide were from Sigma (St.
Louis, Mo. USA). All other chemicals were from Merck
(Darmstadt, D). Scintran, cocktail EX was purchased from
BDH chemicals Ltd (Poole, GB). EI A 96 wells microtitre plates
with high binding capacity were from Costar (Cambridge, Ma,
USA).
Human specimens
Blood from 96 supposed healthy subjects attending the Centre
for Preventive Medicine (Vandoeuvre—Nancy, F) for health
screening was collected in tubes containing clot activator (from
Becton Dickinson, Mountain View, Ca, USA) and centrifuged
at 1200g for 10 minutes. Serum was then frozen at — 20 °C
until analysis.
Whole mixed saliva was collected (between 8.00 and 9.00 a. m.)
from the same population using salivette Systems (Sarstedt,
N mbrecht, D). After centrifugation at 1200g for 10 minutes
the clear saliva was analysed or frozen at —20 °C.
Radio-immuno-assay (RIA)
The assay was performed in glass tubes (10x75 mm). Tris
buffer (200 μΐ) pH 7.4 (Tris-HCl 10 mmol/1 containing 150
mmol/1 of NaCl and l g of gelatin per litre) was added to 100
μΐ of [3H]cotinine in Tris buffer (Ag*), 100 μΐ of Standard or
sample (Ag), and 100 μΐ of antiserum in Tris buffer (Ab), then
incubated ovcrnight at 4 °C. A Suspension (500 μΐ) of charcoal-
dextran (2.2 g/l in Tris buffer) was added with stirring, and the
tubes were incubated at 4°C for 10 min for adsorption of the
free antigen. After cenlrifugation at 3000 g for 15 min at 4 °C,
500 μΐ of supernatant were mixed with 10ml of scintillation
cocktail and counted in a Beckman counter (LS 1801).
The amounts of Ag in physiological fluids were determined
using a Standard curve.
One site enzymometric assay (ELISA)
Preparation of specific reagents
Anti-cotinine imniunoglobulins G were separated on a column
of Protein A Sepharose. After overnight dialysis against 100
mmol/1 sodium bicarbonate pH 8.0 at 4 °C, IgG were concen-
trated using ultrafiltration (l g/l) and stored at ^20°C until
use.
Biotinylation of ahti-c tinirie IgG was performed according to
Costello et al. (8). Biotin conjugate was stored at — 20 °C in
glycerol (for fluorescence micfoscopy) containing 0.2 g sodium
azide per litre. The final volume fraction of glycerol was 0.50.
The optimal dilution was determined for each batch,
Cotinine-polylysine conjugate (2 g/l) was prepared according
to the procedure described by Bjercke et al. (9) and aliquots
were stored at —20 °C until use.
ELISA protocol
The procedure described by Bjercke et al. (9) was modified.
Microtitre plates were cqated with cotinine^polylysine conjugate
by incubating at 4°C overnight. The conjugate was dil ted
1000-fold in phosphate buffer, 3 mmol/1, pH 6.35, and 100 μΐ
of this solution were added to each well. After coating, the
plates were washed three times with "casein buffer" pH 7.6,
containing 10 mmol Tris-HCl, 10 mmol sodium chloride, 10
mmol EDTA and 2 g casein per litre. The unoccupied sites were
blocked by incubating the plates with "casein buffer" for l h
at room temperature; the plates were-then washed three times
with the same buffer and used immediately.
The Standard curve was obtained by adding 50 μΐ of serial
dilutions of cotinine made up in blank serum (pool of sera
collected from 5 non-smokers dil ted l: 5 in "Tris b ffer" for
RIA and in "casein buffer" for ELISA) and 50 μΐ of anti-
cotinine conjugate (dil ted l: 100) in the same buffer. The assay
plate was incubated for 2 h at 37 °C in a wet chamber. The
maximum binding point (B0) was determined by incubating
50 μΐ of anti-cotinine conjugate with 50 μΐ of "casein buffer".
Control wells contained all reagents except anti-cotinine con-
jugate. After incubation, the samples were removed and the
plate washed three times with "casein buffer".
A solution containing 0.66 mg/1 of horse-radish peroxidaser
conjugated extravidin (100 μΐ) was dispensed into each well and
the plate incubated for l h at room temperature.
Finally the plate was washed six times with phosphate buffered
saline pH 7.2, containing 4 g NaHjPO^ · 2H2O, 27 g Na2HPO4
• 12H2O, 8 g NaCl, and 0.5 ml Tween 20 per litre. The activity
of peroxidase bound to the plate was determined by adding to
each well 100 μΐ of freshly prepared Substrate pH 5.5, containing
100 mmol Na2HPO4 · 12H2O, 100 mmol sodium citrate, 3 g o-
phenylenediamine dihydrochloride and 100 μΐ hydrogen ,per-
oxide (30%) per litre. The plate was then incubated for 20-
25 min at room temperature, the reaetion was stopped by
adding 50 μΐ of 3 mol/1 hydrochloric acid, and the absorbance
was read at 492 mm on a Titertek Multisk n, MCC/340 (Flow
Laboratories limited, Rickmanswortli, UK).
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Results
Optimization of the assay procedures
RIA: Determination of the appropriate dilutions for
antibody (Ab) and labelled antigen (Ag*)
The dilution of Ab able to bind 50% of a known
amount of Ag* was chosen. Two dilutions of Ag*
were tested (20000 or 10000 counts/min). The anti-
body dilution curves were constructed by adding 300
μΐ of Tris buffer, pH 7.4 to 100 μΐ of Ag* and 100 μΐ
of Ab dilutions (l: 5, l: 10, l: 50, l: 100, l: 200 and
l: 500) in the same buffer. All subsequent procedures
were those described in the "radio-immuno-assay"
section. The best dilution of Ab was l: 150, using the
Ag* dilution giving 10000 counts/min. For each new
batch of Ab the best dilution should be evaluated.
ELISA: Optimization ofthe fest
Various dilutions of cotinine-polylysine conjugate
were tested. The best coating was obtained with
l: 1000 dilution. The optimal dilution of the bioti-
nylated antibodies was obtained with l: 100 dilution
in "casein buffer". The best results were obtained with
extravidin-peroxidase conjugate diluted to l: 3000
(0.66 mg/1) in the same buffer.
Incubation conditions
RIA
Various temperatures and incubation times were
tested. The r nge of Inhibition (B/B0 > 0.80) was
obtained after l h incubation at 37 °C or 16 h at 4 °C
(fig.i).
The incubation conditions were chosen s 16h at
4 °C. The sensitivity was highest for low concentra-
tions of cotinine (< 5 μg/l), the slope of the curve
being steeper in this r nge.
ELISA
Several incubation temperatures and times were also
tested to determine the optimal conditions, which
were estimated from the minimal signal/noise ratio
and within-run variability. The best detection limit
(0.1 μ§/1) was obtained after 2 h incubation at 37 °C
. in a wet chamber.
Optimization of the Standard curves
RIA
Figure 2 shows the Standard curve obtained in buffer.
It covered the r nge of cotinine content found in non-
smokers, passive smokers and active smokers (3). It
1.00 η
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Fig. 1. RIA: Standard curves in buffer under various incuba-
tion conditions:
o-o l h at 37 °C; x-x 3 h at 37 °C; o-n 16 h at
4°C.
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Fig. 2. RIA and ELISA Standard curves for cotinine under
optimized incubation conditions:
·-· RIA (16 h at 4 °C in buffer)
H-· ELISA (2 h at 37 °C in blank serum)
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was very reproducible, showing day to day coefficients
of Variation of 2.9% for 50 μ§/1 and 3.7% for 500
(n = 10). The detection limit of the test was 0.1
800-
Standard curves made up in physiological fluids, i. e.
serum and saliva, gave a similar slope and dynamic
r nge.
ELISA
Figure 2 shows the Standard curve of cotinine made
in blank serum. This Standard curve was reproducible
when measured on 10 different days, the coefficients
of Variation being 5.5% for 50 μg/l and 7.7% for 500
μg/l. The detection limit was similar to that of the
RIA.
Precision
The repeatability of the methods was assayed by
measuring the serum cotinine level 30 times consec-
utively in -unique series, while the reproducibility
was determined on 10 different days. The within-run
and day to day coefficients of Variation were less than
8.5% for RIA and less than 6% for ELISA (r nge
200 — 500 μg/l). These Variation coefficients were
greater for the low values found in non-smokers:
50% for 0.1 μ§/1 (RIA) and less than 20% for 20 μ^
(ELISA).
Lineari ty
Sera of smokers were tested (fig. 3). Assays were
performed by RIA and ELISA, with and without
dilutions (1:2, 1:4, 1:10, 1:50) in blank serum.
Good linearity was observed for ELISA. However,
RIA was non-linear for concentrations higher than
400 μ§/1. In order to correlate the results obtained by
both methods the samples to be analysed were diluted
(l : 2) in blank serum.
Recovery
Sera were spiked with cotinine and quantitated in
order to calculate the analytical recovery. The mean
analytical recovery tested for concentrations between
50 and 500 μ§/1 was 98% (r nge 96-104) for RIA
and 105% (r nge 103-107) for ELISA, which was
acceptable for both methods.
Stability in serum
A single freezing-thawing cycle (-20°C/room tem-
perature, performed over 48 h) did not give any Var-
iation in serum cotinine level. Additional cycles pro-
duced decreases of serum cotinine (—10 to —33%)
and must be avoided.
0 0.2 OA 0.6 0.8 1Ό
Sample dilution
Fig. 3. Linearity ranges for RIA (p-·) and ELISA (p—·).
Sample assays (sera)
Figure 4 shows correlation curve for serum cotinine
from 52 smokers and 44 non-smokers measured by
ELISA and RIA. Good agreement was found between
RIA and ELISA (RIA = 0.8736 ELISA + 3.4495;
r = 0.97; n = 96).
1000η
200 400 600
Cotinine (ELISA) [pg/l]
1000
Fig. 4. Correlation between RIA and ELISA procedures.
Standard Inhibition curves were determined in blank
serum diluted (l: 5) in "casein buffer" for ELiSA and
gelatin buffer for RIA. The samples tested were diluted
in the blank serum (l: 2, l: 4) and the mean results were
used. n = 96. - ?
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The usual values for smokers and non-smokers are
indicated in table l.
Tab. 1. Serum cotinine levels obtained for active smokers and
non-smokers using RIA and ELISA
RIA
x ± s (μg/l)
r nge fog/l)
ELISA
x ± s fog/l)
r nge (μg/l)
Active sraokers
n = 52
249.2 + 144.0
70 ± 800
278.2 + 159.6
50 - 1000
Non-smokers
n = 44
2.58 + 5.42
0.1 -27.5
2.74 + 4.19
0.1 - 17.0
Discussion
In order to easily discriminate non-smokers from
smokers it is necessary to increase the detection limit
and the sensitivity of cotinine measurements, and
many modifications have been attempted.
Radio-immuno-assays for the measurement of cotin-
ine are classically modifications of the Langone tech-
nique (6) using [3H]cotinine and polyclonal antiserum.
In these methods a second antibody was used for
separating the complexes, and this Step usually re-
quired 16 h. Matsukura et al. (10) and Waldei al. (11)
proposed ammonium sulphate precipitation and chlo-
roform extraction for the determination of the cotin-
ine level in urine. Many modifications were tested and
the lowest detection limit was 0.37 μg/l of cotinine by
radio-immuno-assay and 0.2 μg/l by gas-chromatog-
raphy using nitrogen-selective detection (4, 7, 12—
14). Using 125I labelling and incubating Standard or
plasma samples with the antiserum for l h or for 24 h
(non-equilibrium and equilibrium, respectively), a de-
tection limit of 10 μg/l was attained. 3H labelling is
superior to the use of the [125I]tyramine derivative, s
it permits complete Inhibition (15).
Our RIA method uses a polyclonal antiserum,
[3H]cotinine and charcoal^dextran to specifically bind
free antigen species in a short time (10 min).
The comparison (tab. 2) of this modified RIA with
that previously described shows that our method gives
a better detection limit (0.1 μg/l) than all other pub-
lished techniques. Surprisingly, linearity is maintained
only up to 400 μ§/1. This pseudo-hook effect is rare
in competitive techniques. It may be related to partial
release of adsorbed labelled antigen in the presence
of high concentrations of cotinine (16). A previous
dilution of the sample avoids this effect and allows
reliable correlation of RIA and ELISA.
Tab. 2. Comparison of various cotinine determinations using
RIA
Labelling
I25I. Ή
I2SJ
I25][
125I, 3Hi25l
125J
125I
125J
3H
Fluid
serum
urine
serum
urine, saliva
urine
serum
serum
hair
serum
Limit of
detection
(Mg/1)
2
2
10
0.37
1
0.5
2
1
0.1
Reference
(6)
(10)
(5)
(7)
(11)
(4)(13)
(12)
this work
The proposed ELISA does not use commercially
available reagents but i t has the ad van tage of being
more rapid than RIA. The detection limit was similar
to RIA (0.1 μg/l). The I50 values in the respective
methods were determined (fig. 2). With the RIA, 10 ng
of cotinine gave 50% Inhibition, whereas 340 ng of
cotinine were required with ELISA. Using mono-
clonal antibodies ELISA assays are claimed to be
5 — 10 times more sensitive (9). The use of ELISA
avoids technical precautions, expensive reagents and
a long working time. ELISA is preferable for epide-
miological investigation of the risks due to tobacco
smoking.
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